Online

ESTRO 2020

Session Item

Poster highlights 21 PH: Predictive modelling
8300
Poster Highlights
Physics
14:23 - 14:31
Radiotherapy of prostate cancer:impact of treatment characteristics on the incidence of second tumor
Silvia Cammelli, Italy
PH-0648

Abstract

Radiotherapy of prostate cancer:impact of treatment characteristics on the incidence of second tumor
Authors: Francesco Deodato.(Fondazione "Giovanni Paolo II", UO di Radioterapia- Università Cattolica del Sacro Cuore, Campobasso, Italy), Gabriella Macchia.(Fondazione "Giovanni Paolo II", UO di Radioterapia- Università Cattolica del Sacro Cuore, Campobasso, Italy), Alessio Giuseppe Morganti.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Maria Ntreta.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Erica Scirocco.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Giambattista Siepe.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Vincenzo Valentini.(Fondazione Policlinico Universitario A. Gemelli- IRCCS, UOC di Radioterapia- Dipartimento di Scienze Radiologiche- Radioterapiche ed Ematologiche, Roma, Italy), Anna Rita Alitto.(Fondazione Policlinico Universitario A. Gemelli- IRCCS, UOC di Radioterapia- Dipartimento di Scienze Radiologiche- Radioterapiche ed Ematologiche, Roma, Italy), Silvia Bisello.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Milly Buwenge.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Silvia Cammelli.(Radiation Oncology Center, Department of Experimental- Diagnostic and Specialty Medicine - DIMES-Azienda Ospedaliera-Universitaria S.Orsola-Malpighi, Bologna, Italy), Savino Cilla.(Fondazione "Giovanni Paolo II", UO di Fisica Sanitaria- Università Cattolica del Sacro Cuore, Campobasso, Italy)
Show Affiliations
Purpose or Objective

It has been hypothesized that radiotherapy (RT) techniques delivering radiations to larger volumes (IMRT, VMAT) are potentially associated with a higher risk of second primary tumors. The aim of this study was to analyse the impact of RT technique (3D-CRT vs IMRT/VMAT) on the incidence of second tumors in prosate cancer (PCa) patients.  

Material and Methods

A retrospective study on 2526 previously irradiated PCa patients was performed. Patients were treated with 3D-CRT (21.3%), IMRT (68.1%), or VMAT (10.6%). Second tumors incidence was analysed in 3 categories: pelvic, pelvic and abdominal, and “any site”. The correlation with RT technique was analysed using log-rank test and Cox’s proportional hazard method.

Results

With a median follow-up of 72 months (range: 9-185), 92 (3.6%) cases of second tumors were recorded with 48 months (range: 9-152) median interval from RT. Actuarial 10-year second tumor free survival (STFS) was 87.3%. Ten-year STFS in patients treated with 3D-CRT and IMRT/VMAT was 85.5% and 84.5%, respectively (p: .627). A significantly higher 10-year cumulative incidence of second tumors in the pelvis was registered in patients treated with IMRT/VMAT compared to 3D-CRT (10.7% vs 6.0%; p: .033). This lower incidence of second pelvic cancers in patients treated with 3D-CRT was confirmed at multivariable analysis (HR: 2.42, 95%CI: 1.07-5.47, p: .034). 

Conclusion

The incidence of second pelvic tumors after RT of PCa showed a significant correlation with treatment technique. Further analyses in larger series with prolonged follow-up are needed to confirm these results.